Simcere and Stanford partner to develop IPF therapies

Monday, June 15, 2026Salong DebbarmaView original

Simcere Pharmaceutical has entered a research collaboration agreement with Stanford Medicine to develop new therapies for IPF.

Read the full article on the original site.